Phase II Gleevec Idiopathic Hypereosinophilic Syndrome

NCT00230334 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped terminated by PI due to insufficient accrual

Conditions

Eosinophilia
Hypereosinophilic Syndrome

Interventions

DRUG: Gleevec

Sponsor

Steven E. Coutre

Collaborators

[object Object]